SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.33
arrow_upward
+1.53%(+0.020) 1D
$1.32
arrow_downward
-0.75% (-0.0100)bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.30
High
$1.37
Low
$1.30
Mkt. cap
758.13K
Avg. vol.
2.33M
Volume
22.17K
52-wk high
$16.30
52-wk low
$1.27
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
Open
$1.30
High
$1.37
Low
$1.30
Mkt. cap
758.13K
Avg. vol.
2.33M
Volume
22.17K
52-wk high
$16.30
52-wk low
$1.27
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
The Motley Fool
·
3 minutes ago
The S&P 500 Hasn't Looked This Cheap Based on a Popular Metric in Decades. Should You Buy Stocks Now?
Stock Traders Daily
·
4 hours ago
(TDIV) Price Dynamics and Execution-Aware Positioning
Simply Wall Street
·
1 hour ago
3 Consumer Staples Stocks Tied To Rising Pet Care Spending
Business Insider
·
1 day ago
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR